Veidlapa Nr. M-3 (8)
Study Course Description
Nosaukums angliski
Course Code
RKA_040
Branch of Science
Anatomy; Clinical medicine
ECTS
3.00
Target Audience
Medicine
LQF
Level 8
Study Course Implementer
Course Supervisor
Andris Skride
Residency Speciality
Speciality
Cardiologist
Supervisor of Medical Speciality
Andris Skride
Contacts
-
About Study Course
Objective
-
Study Course Theme Plan
FULL-TIME
Part 1
Total ECTS (Creditpoints):
3.00
Number of Residency Seminars:
0
Length (weeks):
2
Final Examination:
Residency exam (Theory and practice)
Bibliography
Required Reading
1.
Humbert M et al: 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J. 43(38):3618-731, 2022 Simonneau G et al: Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 53(1):1801913, 2019
2.
Hoeper MM et al: COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension. Eur Respir J. 60(1):2102311, 2022
3.
Frost A et al: Diagnosis of pulmonary hypertension. Eur Respir J. 53(1):1801904, 2019
4.
Klinger JR et al: Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest. 155(3):565-86, 2019
5.
Morrell NW et al: Genetics and genomics of pulmonary arterial hypertension. Eur Respir J. 53(1):1801899, 2019
6.
Sharma M et al: Revisiting a distinct entity in pulmonary vascular disease: chronic thromboembolic pulmonary hypertension (CTEPH). Medicina (Kaunas). 57(4):355, 2021
7.
Konstantinides SV et al: 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 41(4):543-603, 2020
8.
Moore C et al: Challenges and changes to the management of pulmonary embolism in the emergency department. Clin Chest Med. 39(3):539-47, 2018
9.
Stevens SM et al: Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report. Chest. ePub, 2021
10.
Sanz J., et al.: Anatomy, function, and dysfunction of the right ventricle . J Am Coll Cardiol 2019; 3 (12): pp. 1463-1482.
11.
Repessé X., et al.: Acute cor pulmonale in ARDS: rationale for protecting the right ventricle . Chest 2015; 147 (1): pp. 259-265
12.
Ghofrani H.A., et al.: Acute effects of riociguat in borderline or manifest pulmonary hypertension associated with chronic obstructive pulmonary disease . Pulm Circ 2015; 5 (2): pp. 296-304